Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients

Adrián Curran(Lexington City Schools), Esteban Ribera(Hospital Terrassa), Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Hernando Knobel(Hospital General de Granollers), Pablo Ryan, Jesús Troya(Hospital Universitario Infanta Leonor), Arkaitz Imaz(Bellvitge University Hospital), Peré Domingo(Hospital de Sant Pau), Estebán Martínez(Instituto de Salud Carlos III), Jhon Rojas(Hospital Clínic de Barcelona), Daniel Podzamczer(Bellvitge University Hospital), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Félix Gutiérrez(Universitat de Miguel Hernández d'Elx)
Journal of Antimicrobial Chemotherapy
September 2, 2016
10.1093/jac/dkw347
Cited by 10

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476